Primer: Qualigen Therapeutics (QLGN US) - Sep 2026
Strategic & Operational Profile: Qualigen Therapeutics, Inc. is an early-stage clinical biotechnology company focused on developing...
IPO Databook: AIxCrypto Holdings (AIXC US) - Sep 2026
AIxCrypto Holdings, Inc. is a technology infrastructure company focused on AI and blockchain-based programmable systems. It develops software...
Qualigen Therapeutics (QLGN US): Synthetic Expert Call Transcript (29 Jul 2026)
Legacy Liabilities Isolation via CVRs: The pivot from Qualigen Therapeutics to AIxCrypto Holdings (AIXC) isolated high-risk oncology liabilities,...
No more insights